LARIAM 250 ROCHE (Lariam 250 mg)
Generic Name: mefloquine
Pill imprint LARIAM 250 ROCHE has been identified as Lariam 250 mg.
Lariam is used in the treatment of malaria prevention; malaria and belongs to the drug class antimalarial quinolines. There is no proven risk in humans during pregnancy. Lariam 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- LARIAM 250 ROCHE
- 250 mg
- Prescription only
- Drug Class:
- Antimalarial quinolines
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Roche Laboratories
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|54569-2965||A-S Medication Solutions, LLC (repackager)|
|55289-0780||PDRX Pharmaceuticals Inc (repackager)|
|00247-0643||Prescript Pharmaceuticals (repackager)|
|54868-3178||Physicians Total Care Inc (repackager)|
|52959-0583||H.J. Harkins Company, Inc (repackager)|
|57866-9074||Direct Dispensing Inc (repackager)|
|49999-0655||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Lariam (mefloquine)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.